Girodet PO - Search Results

1

[Real-life use of inhaler devices for chronic obstructive pulmonary disease in primary care].

Girodet PO, Raherison C, Abouelfath A, Lignot S, Depont F, Moore N, Molimard M. Girodet PO, et al. Therapie. 2003 Nov-Dec;58(6):499-504. doi: 10.2515/therapie:2003081. Therapie. 2003. PMID: 15058493 French.

2

Strategies for Identifying Biomarkers in Severe Asthma.

Girodet PO. Girodet PO. Am J Respir Crit Care Med. 2024 Aug 1;210(3):251-252. doi: 10.1164/rccm.202404-0707ED. Am J Respir Crit Care Med. 2024. PMID: 38701409 Free PMC article. No abstract available.

3

Synthesis and anti-histaminic evaluation of N-phenyl-(alkyl)-5-(dialkylamino)methyl-2-amino-2-oxazolines.

Bosc JJ, Pourageaud F, Girodet PO, Molimard M, Jarry C. Bosc JJ, et al. Among authors: girodet po. J Enzyme Inhib Med Chem. 2003 Apr;18(2):139-45. doi: 10.1080/1475636031000093570. J Enzyme Inhib Med Chem. 2003. PMID: 12943197 Free article.

4

Atypical antipsychotics: from potassium channels to torsade de pointes and sudden death.

Titier K, Girodet PO, Verdoux H, Molimard M, Bégaud B, Haverkamp W, Lader M, Moore N. Titier K, et al. Among authors: girodet po. Drug Saf. 2005;28(1):35-51. doi: 10.2165/00002018-200528010-00003. Drug Saf. 2005. PMID: 15649104 Review.

5

Paradoxal effect of salbutamol in an in vitro model of bronchoprotection.

Girodet PO, Berger P, Martinez B, Marthan R, Advenier C, Molimard M. Girodet PO, et al. Fundam Clin Pharmacol. 2005 Apr;19(2):179-86. doi: 10.1111/j.1472-8206.2005.00320.x. Fundam Clin Pharmacol. 2005. PMID: 15810898

6

Pharmacological approach to evaluate aerosol pulmonary deposition.

Girodet PO, Molimard M. Girodet PO, et al. J Aerosol Med. 2005 Summer;18(2):183-92. doi: 10.1089/jam.2005.18.183. J Aerosol Med. 2005. PMID: 15966772 Review.

7

Inhaled corticosteroids and adrenal insufficiency: prevalence and clinical presentation.

Molimard M, Girodet PO, Pollet C, Fourrier-Réglat A, Daveluy A, Haramburu F, Fayon M, Tabarin A. Molimard M, et al. Among authors: girodet po. Drug Saf. 2008;31(9):769-74. doi: 10.2165/00002018-200831090-00005. Drug Saf. 2008. PMID: 18707191

8

Drug interactions between inhaled corticosteroids and enzymatic inhibitors.

Daveluy A, Raignoux C, Miremont-Salamé G, Girodet PO, Moore N, Haramburu F, Molimard M. Daveluy A, et al. Among authors: girodet po. Eur J Clin Pharmacol. 2009 Jul;65(7):743-5. doi: 10.1007/s00228-009-0653-4. Epub 2009 Apr 28. Eur J Clin Pharmacol. 2009. PMID: 19399485 Free article. No abstract available.

9

The chronic oral administration of arginine aspartate decreases secretion of IGF-1 and IGFBP-3 in healthy volunteers.

Blazejewski S, Georges A, Forest K, Corcuff JB, Abouelfath A, Girodet PO, Kamagate M, Jacquet A, Pillet O, Bordenave L, Moore N. Blazejewski S, et al. Among authors: girodet po. Fundam Clin Pharmacol. 2009 Jun;23(3):339-44. doi: 10.1111/j.1472-8206.2009.00716.x. Fundam Clin Pharmacol. 2009. PMID: 19527301 Clinical Trial.

10

Phytalgic, a food supplement, vs placebo in patients with osteoarthritis of the knee or hip: a randomised double-blind placebo-controlled clinical trial.

Jacquet A, Girodet PO, Pariente A, Forest K, Mallet L, Moore N. Jacquet A, et al. Among authors: girodet po. Arthritis Res Ther. 2009;11(6):R192. doi: 10.1186/ar2891. Epub 2009 Dec 16. Arthritis Res Ther. 2009. PMID: 20015358 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

95 results

Search Page

Filters